Physician profile
Bruce H Paley
NPI 1619993375
$2,090.50
in general payments reported to CMS, 2019-2025
20 companies · $101 in 2025
The $101 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,036 · 2020: $30.00 · 2021: $19.09 · 2022: $127 · 2023: $411 · 2024: $366 · 2025: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $878.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $878.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $495.03 | 2019-2024 | |
| Lilly USA, LLC | $184.09 | 2019-2024 | Mounjaro |
| Pfizer INC. | $163.18 | 2019-2023 | |
| Sun Pharmaceutical Industries INC. | $160.46 | 2019 | |
| Amgen INC. | $150.83 | 2020-2024 | Repatha |
| Smith+Nephew, INC. | $126.50 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $109.64 | 2019 | |
| Idorsia Pharmaceuticals US INC | $100.94 | 2023 | Quviviq |
| Relievant Medsystems, INC. | $85.54 | 2023 | Intracept |
| Genzyme Corporation | $79.07 | 2019 | |
| Abiomed | $78.86 | 2025 | |
| Janssen Pharmaceuticals, INC | $72.74 | 2019 | |
| Janssen Scientific Affairs, LLC | $68.26 | 2019 | |
| Janssen Biotech, INC. | $67.10 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $38.43 | 2019-2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $34.54 | 2024 | Inspire |
| Novartis Pharmaceuticals Corporation | $22.37 | 2019 | |
| Almirall LLC | $22.34 | 2025 | Klisyri |
| Mayne Pharma Commercial LLC | $16.70 | 2019 | |
| Merck Sharp & Dohme LLC | $13.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Paley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.